Research Article

Dynamics of SOX2 and CDX2 Expression in Barrett’s Mucosa

Table 1

Primary antibodies and immunohistochemistry conditions used in this study.

AntibodyCloneAntigen retrieval bufferAntigen retrieval conditionsDilutionIncubation time (min)LocalizationSource

CDX2CDX2-88Citrate buffer 10 mM pH 6.040 minutes at 98°C1 : 50Overnight (4°C)NuclearBiogenex, San Ramon, CA
MUC2PMH10.1 U/mL neuraminidase2 h at 37°CUndilutedOvernight (4°C)CytoplasmaticSupernatant [28]
MUC5ACCLH2NoneNone1 : 10Overnight (4°C)CytoplasmaticSupernatant [28]
MUC6CLH5NoneNone1 : 10Overnight (4°C)CytoplasmaticSupernatant [28]
SOX2SP-76EDTA 10 mM pH 8.040 minutes at 98°C1 : 501 h (room temperature)NuclearCell Marque, Rockling, CA

Neuraminidase from Clostridium perfringens type VI (Sigma) was diluted in sodium acetate buffer (pH 5.5).